Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
Clinical trial NCT04562389 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04562389
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-11
- Primary completion
- 2026-02-20
- Enrollment
- 353
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.